Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Pharmos
AddedFeb 15, 2024
UpdatedJun 18, 2026
Pharmos

Pharmos

Public

W World Corp.: A bio-pharmaceutical firm innovating new drugs for neuroinflammatory disorders.

HQ
Iselin, NJ, US
Founded
1982
Overview
Compare
Fundraising
Employees
Website

Pharmos Corporation, founded with a mission to combat neuroinflammatory disorders, is a bio-pharmaceutical company dedicated to discovering and developing innovative drugs. The company's core vision is to enhance the quality of life for individuals suffering from these conditions through advanced medical research and pharmaceutical solutions. Pharmos offers a portfolio of drug candidates aimed at treating various neuroinflammatory diseases, positioning itself as a key player in the biopharma market.

Notable figures associated with Pharmos include leading researchers and scientists who drive the company's innovation. Pharmos has garnered attention from significant investors in the pharmaceutical industry, contributing to its growth and development. Key achievements include the successful development of several promising drug candidates, which have shown potential in clinical trials. The overall impact of Pharmos lies in its commitment to reducing the burden of neuroinflammatory disorders through cutting-edge drug discovery and development.

Pharmos - Similar Companies

Bioscience Pharma Partners logo

Bioscience Pharma Partners

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

Bayer Pharmaceuticals logo

Bayer Pharmaceuticals

bayer.com

Pharmazz logo

Pharmazz

pharmazz.com

Pharmatrophix logo

Pharmatrophix

pharmatrophix.com

Woolsey Pharmaceuticals logo

Woolsey Pharmaceuticals

woolseypharma.com

Corbus Pharmaceuticals Holdings logo

Corbus Pharmaceuticals Holdings

corbuspharma.com

Bristol Myers Squibb logo

Bristol Myers Squibb

bms.com

PIN Pharma logo

PIN Pharma

pinpharma.com

Collegium Pharmaceutical logo

Collegium Pharmaceutical

Royalty Pharma logo

Royalty Pharma

royaltypharma.com

Eolo Pharma logo

Eolo Pharma

eolo-pharma.com

Thar Pharmaceuticals logo

Thar Pharmaceuticals

tharpharma.com

MBC Pharma logo

MBC Pharma

mbcpharma.com

Amphastar Pharmaceuticals logo

Amphastar Pharmaceuticals

amphastar.com

Pharmos - Quick Facts

Who are Pharmos' competitors?

Companies similar to Pharmos include Bioscience Pharma Partners, NeuroTherapeutics Pharma, Bayer Pharmaceuticals and Pharmazz.

When was Pharmos founded?

Pharmos was founded in 1982.

Where is Pharmos' headquarters located?

Pharmos' headquarters is located in Iselin, NJ, US.

When was Pharmos' last funding round?

Pharmos' most recent funding round was for $1.5M (USD) in March 2007.

How much has Pharmos raised to-date?

As of Mar 29, 2007, Pharmos has raised a total of $9.5M (USD).

How many employees does Pharmos have?

Pharmos has 2 employees as of Feb 4, 2024.

Pharmos - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Development
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified